Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein
- PMID: 18092885
- PMCID: PMC2140086
- DOI: 10.1371/journal.pmed.0040337
Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein
Abstract
Background: Plasmodium vivax invasion requires interaction between the human Duffy antigen on the surface of erythrocytes and the P. vivax Duffy binding protein (PvDBP) expressed by the parasite. Given that Duffy-negative individuals are resistant and that Duffy-negative heterozygotes show reduced susceptibility to blood-stage infection, we hypothesized that antibodies directed against region two of P. vivax Duffy binding protein (PvDBPII) would inhibit P. vivax invasion of human erythrocytes.
Methods and findings: Using a recombinant region two of the P. vivax Duffy binding protein (rPvDBPII), polyclonal antibodies were generated from immunized rabbits and affinity purified from the pooled sera of 14 P. vivax-exposed Papua New Guineans. It was determined by ELISA and by flow cytometry, respectively, that both rabbit and human antibodies inhibited binding of rPvDBPII to the Duffy antigen N-terminal region and to Duffy-positive human erythrocytes. Additionally, using immunofluorescent microscopy, the antibodies were shown to attach to native PvDBP on the apical end of the P. vivax merozoite. In vitro invasion assays, using blood isolates from individuals in the Mae Sot district of Thailand, showed that addition of rabbit anti-PvDBPII Ab or serum (antibodies against, or serum containing antibodies against, region two of the Plasmodium vivax Duffy binding protein) (1:100) reduced the number of parasite invasions by up to 64%, while pooled PvDBPII antisera from P. vivax-exposed people reduced P. vivax invasion by up to 54%.
Conclusions: These results show, for what we believe to be the first time, that both rabbit and human antibodies directed against PvDBPII reduce invasion efficiency of wild P. vivax isolated from infected patients, and suggest that a PvDBP-based vaccine may reduce human blood-stage P. vivax infection.
Conflict of interest statement
Figures
Comment in
-
Towards a vaccine against Plasmodium vivax malaria.PLoS Med. 2007 Dec;4(12):e350. doi: 10.1371/journal.pmed.0040350. PLoS Med. 2007. PMID: 18092888 Free PMC article.
Similar articles
-
The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals.PLoS Pathog. 2020 Feb 20;16(2):e1008258. doi: 10.1371/journal.ppat.1008258. eCollection 2020 Feb. PLoS Pathog. 2020. PMID: 32078643 Free PMC article. Review.
-
Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.Sci Rep. 2018 Jul 12;8(1):10511. doi: 10.1038/s41598-018-28757-4. Sci Rep. 2018. PMID: 30002416 Free PMC article.
-
Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection.Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8363-8. doi: 10.1073/pnas.0800371105. Epub 2008 Jun 3. Proc Natl Acad Sci U S A. 2008. PMID: 18523022 Free PMC article.
-
Towards a vaccine against Plasmodium vivax malaria.PLoS Med. 2007 Dec;4(12):e350. doi: 10.1371/journal.pmed.0040350. PLoS Med. 2007. PMID: 18092888 Free PMC article.
-
Targeting the Plasmodium vivax Duffy-binding protein.Trends Parasitol. 2008 Jan;24(1):29-34. doi: 10.1016/j.pt.2007.10.004. Epub 2007 Nov 26. Trends Parasitol. 2008. PMID: 18023618 Review.
Cited by
-
Genetic differentiation of Plasmodium vivax duffy binding protein in Ethiopia and comparison with other geographical isolates.Malar J. 2024 Feb 23;23(1):55. doi: 10.1186/s12936-024-04887-1. Malar J. 2024. PMID: 38395885 Free PMC article.
-
Development of a Plasmodium vivax biobank for functional ex vivo assays.Malar J. 2023 Aug 31;22(1):250. doi: 10.1186/s12936-023-04668-2. Malar J. 2023. PMID: 37653486 Free PMC article.
-
Genetic diversity and natural selection of Plasmodium vivax reticulocyte invasion genes in Ecuador.Malar J. 2023 Aug 3;22(1):225. doi: 10.1186/s12936-023-04640-0. Malar J. 2023. PMID: 37537581 Free PMC article.
-
Designing an effective malaria vaccine targeting Plasmodium vivax Duffy-binding protein.Trends Parasitol. 2023 Oct;39(10):850-858. doi: 10.1016/j.pt.2023.06.011. Epub 2023 Jul 21. Trends Parasitol. 2023. PMID: 37481347 Free PMC article. Review.
-
Genetic diversity and molecular evolution of Plasmodium vivax Duffy Binding Protein and Merozoite Surface Protein-1 in northwestern Thailand.Infect Genet Evol. 2023 Sep;113:105467. doi: 10.1016/j.meegid.2023.105467. Epub 2023 Jun 15. Infect Genet Evol. 2023. PMID: 37330027 Free PMC article.
References
-
- Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64:97–106. - PubMed
-
- Baum J, Maier AG, Good RT, Simpson KM, Cowman AF. Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions. PLoS Pathog. 2005;1:e37. doi: 10.1371/journal.ppat.0010037. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials